Injection paradigm for administration of botulinum toxins | Patent Publication Number 20190060423

US 20190060423 A1
Patent NumberUS 10729751 B2
Application Number16173664
Filled DateOct 29, 2018
Priority DateMar 13, 2015
Publication DateFeb 28, 2019
Original AssigneeAbbvie Inc.
Current AssigneeAllergan
Inventor/ApplicantsMitchell F. Brin
Andrew M. Blumenfeld
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.